好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

KonectomTM Smartphone-based Digital Outcome Assessments for Adults Living with Spinal Muscular Atrophy (SMA): A Conceptual Framework
General Neurology
General Neurology Posters (7:00 AM-5:00 PM)
010
To develop a conceptual framework supporting the KonectomTM smartphone based digital solution that enables adults living with SMA to quantitatively self-assess motor function in the real world environment.
SMA is a progressive neuromuscular disorder characterized by impaired motor function. While symptom onset for the majority occurs in early childhood, adult onset also occurs. The size of the population of adults living with SMA may grow over time due to rapid advances in disease-modifying therapies for SMA. To meet the increasing demand for clinical care for adults living with SMA, it is necessary to develop outcome assessments quantifying motor functions that are sensitive to disease progression and relevant to real world abilities.

We developed a conceptual framework capable of capturing the heterogenous symptomatology in three functionally distinct groups of adults living with SMA (walkers, sitters and non-sitters). Development comprised: A) A targeted literature search focused on neuromuscular disorders to identify common neurological domains evaluated in these disorders; B) Creation of an adult SMA conceptual framework covering signs and symptoms (nineteen signs and symptoms grouped into four domains); and C) Seven semi-structured interviews conducted with adult SMA experts (five physicians and two physiotherapists).

Experts endorsed the completeness of the conceptual framework for describing the three SMA functional profiles. Fatigability and smartphone typing skills are considered useful to monitor disease progression for all functional profiles. Upper limb function and speech/voice are expected to provide more information about disease progression and impacts on quality of life for sitters and non-sitters, while lower limb function is more relevant to walkers.

We have developed a comprehensive conceptual framework that will enable us to design and develop digital outcome assessments to quantify functional abilities, quality of movement, and other non-motor signs that are clinically meaningful for a heterogeneous group of adults living with SMA.

Sponsored by Biogen

Authors/Disclosures
Eduardo Arteaga Bracho (Biogen)
PRESENTER
Eduardo Arteaga Bracho has nothing to disclose.
Yi Dai No disclosure on file
Vivian E. Drory, MD (Tel-Aviv Medical Center) Prof. Drory has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Prof. Drory has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Prof. Drory has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Prof. Drory has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Prof. Drory has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medison Pharma. The institution of Prof. Drory has received research support from Neurosense Therapeutics. The institution of Prof. Drory has received research support from AB Science. The institution of Prof. Drory has received research support from Biogen. The institution of Prof. Drory has received research support from Neuralight.
Tina Duong Tina Duong has received personal compensation for serving as an employee of Roche. Tina Duong has received personal compensation for serving as an employee of Novartis. Tina Duong has received personal compensation for serving as an employee of Scholar Rock. Tina Duong has received personal compensation for serving as an employee of Genentech. Tina Duong has received personal compensation for serving as an employee of Novartis. Tina Duong has received personal compensation for serving as an employee of Sarepta. Tina Duong has received personal compensation for serving as an employee of Biogen. Tina Duong has received personal compensation for serving as an employee of Audentes. Tina Duong has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Tina Duong has received personal compensation in the range of $0-$499 for serving as a Consultant for Audentes. Tina Duong has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Tina Duong has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Tina Duong has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Tina Duong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Tina Duong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genentech. Tina Duong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sarepta. Tina Duong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for biogen. The institution of Tina Duong has received research support from biogen. The institution of Tina Duong has received research support from scholar rock.
Christoph Kleinschnitz, MD (University Hospitals Essen, Dep. of Neurology) Dr. Kleinschnitz has nothing to disclose.
No disclosure on file
Sabrina Sacconi, MD Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LUPIN. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SANOFI. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIOGEN. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AMICUS. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ALEXION. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for FULCRUM THERAPEUTICS. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for AXELYS. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for OLOGY. The institution of Dr. Sacconi has received research support from Solve FSHD.
Valeria A. Sansone, MD (The NEMO Clinical Center - Neurorehabilitation Unit, University of Milan) Dr. Sansone has nothing to disclose.
Marta Valente (Biogen Idec) No disclosure on file
No disclosure on file
Shibeshih Belachew, MD Dr. Belachew has received personal compensation for serving as an employee of Biogen Inc. Dr. Belachew has received stock or an ownership interest from Biogen Inc.
Christine C. Guo, PhD No disclosure on file